miR-130b |
miR-130b promotes EMT by ZEB1 |
Endometrial cancer |
[179] |
miR-30d |
miR-30d impacts on the sector to promote ECM for metastasis |
Breast cancer |
[124] |
miR-21-3p/miR-769-3p |
p53 R273H activates fibroblasts by exosomal miR-21-3p |
Lung cancer |
[113] |
miR-1246 |
Cancers with mutp53 shed exosomes containing miR-1246 induce a miR-1246-dependent reprogram of TAMs to a tumor-suppurative status |
Colon cancer |
[180] |
miR-34 |
This tumor-suppressive miRNA is usually downregulated in p53-mutated cancers |
Multiple cancers |
[117, 181] |
miR-223-3p |
Mutp53 directly binds to the promoter region of miR-223-3p that can suppress tumor proliferation and migration |
Lung cancer |
[123] |
miR-200 |
miR-200 suppressed by mutp53 losses the ability to inhibit metastasis |
NSCLC |
[182] |
Let-7i |
let-7i inhibits invasion and metastasis by repressing E2F5, LIN28B, MYC, and NRAS |
Breast cancer |
[52] |
miR-142-3p |
Upregulation of Dnmt1 promotes miR-142-3p hypermethylation of its locus |
Pancreatic ductal adenocarcinoma |
[183] |
LincRNA-p21 |
LincRNA-p21 cannot be activated by mutp53 in response to DNA damage |
HNSCC |
[137] |
AGPG |
p53 mutations lose the transcriptionally suppress function to inhibit AGPG expression, and upregulated AGPG stabilizes PFKFB3 to promote glycolysis |
Esophageal squamous cell carcinoma |
[90] |
MALAT1 |
MALAT1 acts as a bridge between mutp53 and ID4 to modulate VEGFA isoforms expression |
Breast cancer |
[138] |
Lnc273-31/34 |
p53 R273H specific upregulates lnc273-31 to maintain self-renew of colorectal CSCs |
Colorectal cancer |
[184] |
lncMIR205HG |
Mutp53 recruited by NF-YA and E2F1 to the promoter of MIR205HG to upregulate lncMIR205HG to promote cancer progression |
HNSCC |
[185] |
LINC00460 |
Upregulation of LINC00460 by mutp53 increases mutp53 levels through competitively binding to miRNAs targeting mutp53 |
Colorectal cancer |
[186] |
CircPVT1 |
CircPVT1 is upregulated by mutp53 in HNSCC patients to promote cancer proliferation by miR-497-5p |
HNSCC |
[187] |
Circ-CCNB1 |
Circ-CCNB1 is suppressed in p53-mutated cancer, and expression of circ-CCNB1 activates the H2AX-dependent tumor suppressor Bclaf1 only in cancer cells harboring mutp53 |
Breast cancer |
[140] |